India’s pharmaceutical exports recorded a strong start to FY2026-27, rising 6.8% year-on-year to US$8.1 billion in Q1, according to data from the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
The growth highlights continued international demand for Indian medicines, particularly generic drugs, vaccines and pharmaceutical intermediates. The United States remained India’s largest pharmaceutical export market, accounting for US$2.50 billion, or nearly 31% of total pharma exports during the quarter.
The latest performance reinforces India’s position as a major global pharmaceutical manufacturing and export hub, supported by competitive production capabilities, regulatory compliance and expanding market diversification.
Key Highlights
- India’s pharma exports: US$8.1 billion in Q1 FY2026-27
- Year-on-year growth: 6.8%
- Largest export market: United States
- Drug formulations and biologicals: US$5.98 billion
- Bulk drugs and intermediates: US$1.36 billion
- Vaccine exports: US$0.39 billion, up 35.68%
- Surgical products: US$0.21 billion, up 11.95%
- Major regional markets: North America, Europe, Africa and Latin America & Caribbean
- Top 25 destinations: Nearly 70% of India's pharmaceutical exports
- FY2025-26 pharma exports: US$31.11 billion
Pharma Formulations Lead India’s Export Basket
Drug formulations and biologicals continued to dominate India’s pharmaceutical export basket during Q1, generating US$5.98 billion in export revenue.
This category accounted for approximately 73.85% of India’s total pharmaceutical exports and grew 4.14% compared with the same period a year earlier.
Bulk drugs and drug intermediates recorded stronger growth, increasing 13.84% to US$1.36 billion. Vaccine exports delivered one of the fastest growth rates, jumping 35.68% to US$390 million.
India Pharmaceutical Export Categories — Q1 FY2026-27
Export Category
Q1 Export Value
YoY Growth
Share/Significance
Drug formulations & biologicals
US$5.98 bn
4.14%
73.85% of total
Bulk drugs & intermediates
US$1.36 bn
13.84%
2nd-largest category
Vaccines
US$0.39 bn
35.68%
Fastest-growing major category
Surgical products
US$0.21 bn
11.95%
Strong double-digit growth
Total pharmaceutical exports
US$8.10 bn
6.80%
Q1 FY2026-27
U.S. Continues to Drive India’s Pharmaceutical Exports
The United States remained India’s largest pharmaceutical export destination, with shipments valued at approximately US$2.50 billion during Q1.
The U.S. accounted for 30.89% of India’s pharmaceutical exports, underlining the importance of the American market to India’s pharmaceutical manufacturing and export ecosystem.
Brazil, the United Kingdom, the Netherlands and France followed the U.S. among India’s leading country-level export destinations.
The top 25 destinations collectively accounted for nearly 70% of India’s pharmaceutical exports, with shipments worth approximately US$5.65 billion, representing 5.50% year-on-year growth.
Top Pharmaceutical Export Markets
Rank
Market
Q1 Export Value / Position
1
United States
US$2.50 billion
2
Brazil
Major growth market
3
United Kingdom
Key developed market
4
Netherlands
Major European destination
5
France
Growing European market
India’s Pharmaceutical Export Growth Is Becoming More Diversified
While North America continues to be a critical market, India’s pharmaceutical exports are increasingly spread across multiple regions.
North America, Europe, Africa and Latin America & the Caribbean collectively represented nearly three-fourths of India’s pharmaceutical exports during the quarter.
Double-digit growth across several regions, including Europe, Africa, Latin America, ASEAN and South Asia, points to increasing geographical diversification.
This diversification could help Indian pharmaceutical exporters reduce their dependence on individual markets while creating opportunities across emerging healthcare markets.
Growth Drivers Behind India’s Pharma Export Performance
Several factors are supporting the expansion of India’s pharmaceutical exports:
1. Strong Global Demand for Generics
Indian manufacturers remain major suppliers of affordable generic medicines to healthcare systems around the world.
2. Expanding Vaccine Exports
Vaccine shipments grew by more than 35% during Q1, demonstrating India’s continued strength in vaccine manufacturing and international supply.
3. Growing Pharmaceutical Intermediates Demand
Exports of bulk drugs and drug intermediates increased 13.84%, reflecting demand for pharmaceutical inputs and India’s expanding role in global supply chains.
4. Market Diversification
Increasing exports to Europe, Africa, ASEAN, South Asia and Latin America are broadening India’s pharmaceutical trade footprint.
5. Manufacturing Scale and Regulatory Capability
India’s combination of manufacturing capacity, competitive costs, regulatory experience and established global supply relationships continues to support pharmaceutical exports.
June Pharma Exports Also Show Strong Momentum
India’s pharmaceutical exports continued to perform strongly in June.
Pharmaceutical shipments increased 7.13% year-on-year to US$2.81 billion, compared with approximately US$2.62 billion in June of the previous year.
June exports were also 6.86% higher than the US$2.63 billion recorded in May FY2026-27, indicating continued momentum at the beginning of the new financial year.
India’s FY2025-26 Pharma Exports Cross US$31 Billion
India’s pharmaceutical exports reached approximately US$31.11 billion in FY2025-26, representing growth of more than 2% compared with the previous financial year.
The latest Q1 performance suggests that pharmaceutical exports remain an important contributor to India’s broader merchandise export strategy.
What This Means for Global Logistics
The growth in pharmaceutical exports also has implications for the logistics and supply chain industry.
Pharmaceutical products require tightly controlled transportation, documentation and compliance processes. Rising export volumes can increase demand for:
- Temperature-controlled and cold-chain logistics
- Air freight for time-sensitive pharmaceutical shipments
- Pharma-compliant warehousing
- Track-and-trace systems
- Digital shipment documentation
- Customs and regulatory compliance
- Real-time cargo visibility
- Secure last-mile pharmaceutical transportation
For freight forwarders and logistics providers, India’s expanding pharmaceutical trade represents an opportunity to develop more specialized pharma logistics and healthcare supply-chain solutions.
Conclusion
India’s 6.8% growth in pharmaceutical exports to US$8.1 billion during Q1 FY2026-27 signals continued strength in one of the country’s most strategically important export sectors.
The United States remains the dominant market, but strong growth across Europe, Africa, Latin America, ASEAN and South Asia indicates that Indian pharmaceutical companies are increasingly diversifying their global presence.
With vaccine exports, pharmaceutical intermediates and other categories recording strong growth, India’s pharmaceutical industry is positioned to play an increasingly important role in global healthcare supply chains.
For the logistics industry, the trend also points to rising demand for specialized pharma freight forwarding, cold-chain logistics, compliance, visibility and digitally managed supply chains.
Frequently Asked Questions
What was India’s pharmaceutical export value in Q1 FY2026-27?
India exported pharmaceutical products worth approximately US$8.1 billion in Q1 FY2026-27, representing 6.8% year-on-year growth.
Which country is the largest market for Indian pharmaceutical exports?
The United States remained India’s largest pharmaceutical export destination, with exports of approximately US$2.50 billion, representing 30.89% of total pharmaceutical exports during the quarter.
Which pharmaceutical export category is the largest?
Drug formulations and biologicals were the largest category, generating approximately US$5.98 billion and accounting for 73.85% of India’s pharmaceutical exports.
Which pharmaceutical export category grew the fastest?
Vaccine exports recorded the strongest growth among the major categories, increasing 35.68% year-on-year to US$0.39 billion.
How much did India export in pharmaceuticals in FY2025-26?
India’s pharmaceutical exports reached approximately US$31.11 billion in FY2025-26, growing by more than 2% year-on-year.
Why are India's pharmaceutical exports important for logistics?
Pharmaceutical exports require specialized supply-chain capabilities, including temperature-controlled transportation, regulatory documentation, cargo tracking, secure warehousing and fast customs clearance. Rising export volumes can therefore increase demand for specialized pharmaceutical logistics services.
